1) in liver tissues compared to those fed a normal diet (P < 0.05), suggesting the successful induction of NAFLD-like symptoms model. Administration of SJZ, LZ, and FZLZ after NAFLD induction significantly reduced the hepatic levels of the abovementioned indicators to varying degrees (P < 0.05). In particular, FZLZ resulted in lower levels of ALT than did SJZ (P < 0.05) and led to further reduced TG content than did LZ (P < 0.05). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.